As observed upon KI treatment, we confirmed that MAP3K8 stable silencing significantly reduced cell proliferation in all ovarian cancer cell lines tested (Fig. 2d, right panels), without affecting their viability (Supplementary Fig. 3D). The gene discussed is MAP3K8; the disease is ovarian cancer.